Kathy Baker: Founding My Faulty Gene & Surviving Hereditary Cancer
Episode Summary
Kathy Baker grew up in a family that, as she puts it, "looked like a poster for a BRCA mutation" — a sister diagnosed with breast cancer at 31, a mother with three primary cancers, a grandfather lost to aggressive prostate cancer, a great-grandmother lost to pancreatic cancer. And still, when genetic testing became available, Kathy said no. Not out of denial exactly, but out of a fierce instinct to protect her own life from being lived under a shadow. She was diagnosed with breast cancer herself in 2000, treated without ever seeing an oncologist first, and then spent nine years declining the genetic testing her oncologist gently, patiently kept raising — until a single statistic changed her mind.
What happened next is the kind of story that reframes what "protective" actually means. Kathy tested positive for a BRCA1 mutation alongside her sister, honored a promise to her dying mother, and underwent ten hours of piggybacked surgery with three surgeons working in tandem — only to learn, mid-procedure, that she already had early-stage ovarian cancer no one knew was there. It's a story about the long, human runway between having information and being ready to use it, and about what Kathy built afterward: a nonprofit that funds the testing other people can't yet afford, or aren't ready, or don't know they're allowed to ask for.
We Cover
Growing up in a family history so dense with cancer it reads like a genetics textbook — and why that didn't automatically translate to testing
Kathy's decision, in her twenties and thirties, not to pursue early mammograms or testing: "I didn't want to live in fear of cancer"
Her 2000 breast cancer diagnosis, the surgery choices she made without a genetic counselor in the room, and what she'd do differently in hindsight
The nine years her oncologist quietly kept raising genetic testing — and the study that finally moved her to say yes
Testing BRCA1 positive alongside her sister, and the promise she made her dying mother to pursue risk-reducing surgery
The ten-hour, three-surgeon surgery that uncovered an early ovarian cancer no one expected to find
Founding My Faulty Gene in 2020 to fund germline genetic testing for people who fall outside insurance criteria
Why cascade testing — testing the family members of someone with a known mutation — is Kathy's central focus, and why fewer than 10% of relatives ever follow through
The emotional and family-system barriers underneath low cascade testing rates: avoidance, fear, and families that don't talk about hard things
Real-world access barriers: the cost of testing, the lack of paid leave for self-employed patients, and life insurance underwriting for known mutation carriers
Highlights & takeaways
"Not knowing doesn't change whether you have it or not. All it changes is how you can respond — and whether you respond."
"I've already told you I'm not that compliant patient... I am not somebody who would have presented with the vague symptoms of ovarian cancer. I would not be here."
"I was spared for a reason. I really believe that."
"How can I not? I've been given a great gift. How can I not?"
On persuading reluctant family members: "Everyone knows when they see me that I'm coming to talk to them."
"If you have the ability to go and buy a $300 purse, spend that money this month on your own testing."
Content Note
This episode names breast cancer diagnosis and treatment, an unexpected ovarian cancer discovery, a parent's death from cancer, major risk-reducing surgery (double mastectomy, hysterectomy, bilateral salpingo-oophorectomy), family history of multiple cancers across generations, financial strain during cancer treatment, life insurance discrimination against mutation carriers, and the host's own disclosure of losing her mother to ovarian cancer at age ten.
Resources Mentioned
My Faulty Gene — myfaultygene.org — Kathy's nonprofit, funding germline genetic testing for patients who don't meet insurance criteria for coverage
Family Gene Share — familygeneshare.org — an educational video series of patient stories, created to help families start cascade testing conversations
FORCE (Facing Our Risk of Cancer Empowered) — referenced as an ally organization in the hereditary cancer space
OCRA (Ovarian Cancer Research Alliance) — referenced as offering limited free testing under specific guidelines
J Screen — genetic testing and counseling partner organization
KIC (Knowledge is Cancer's Kryptonite) — partner organization referenced in the episode
The Metcalf study — research on ovarian cancer risk in BRCA1/BRCA2 carriers, referenced as the turning point in Kathy's decision to test
Connect
If this episode moved something in you, follow, rate, and share Walking the Genetic Line — it helps this conversation reach the people who need it. Follow Sara Champie, LCSW at @SaraChampieLCSW for more.
Let's walk this line, together.
Additional support
If this episode brought up grief, fear, or decision fatigue around your own genetic risk or family history, you don't have to sit with it alone. Sara Champie, LCSW offers trauma-informed therapy for people navigating hereditary cancer risk, genetic testing decisions, and preventive or reconstructive surgery.
Sara Champie
